Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
The tropomyosin receptor kinase (TRK) fusion protein produced by the fusion of the neurotrophic tyrosine receptor kinase (NTRK) gene is a major oncogenic driver that is rare in a v···【more】
Article source：Captain MedicineRelease date：2024-11-19Recommended：461
How to buy generic larotrectinib?Vitrakvi, a highly selective oral tropomyosin receptor kinase (TRK) inhibitor, larotrectinib, has demonstrated significant activity in adult and pe···【more】
Article source：Captain MedicineRelease date：2024-11-19Recommended：365
1. Product IngredientsEntrectinib is a small molecule tyrosine kinase inhibitor with the chemical name N-(4-(3-(4-(6-(2-fluoro-4-(trifluoromethyl)phenyl)thiazol-2-yl)thiazol-2-yl)p···【more】
Article source：Captain MedicineRelease date：2024-11-18Recommended：465
1. Product IngredientsThe chemical name of afatinib is N-{4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl}-2-(dimethylamino)acetamide, the molecular for···【more】
Article source：Captain MedicineRelease date：2024-11-18Recommended：382
In a phase 1 study, sotorasib showed anticancer activity in patients with advanced solid tumors with KRAS p.G12C mutations, and particularly promising anticancer activity was obser···【more】
Article source：Captain MedicineRelease date：2024-11-15Recommended：366
According to NCCN guidelines, for patients with KRASG12C-mutated non-small cell lung cancer (NSCLC), two drugs are currently approved for second-line therapy, particularly for pati···【more】
Article source：Captain MedicineRelease date：2024-11-15Recommended：448
Cabobrutinib is a tyrosine kinase inhibitor that primarily targets MET, VEGFR and RET proteins for the treatment of medullary thyroid cancer and advanced renal cellsIs Cabozantinib···【more】
Article source：Captain MedicineRelease date：2024-11-14Recommended：402
Pralsetinib is a selective RET kinase inhibitor indicated for the treatment of RET-fused cancers (NSCLC) and RET-altered thyroid cancers.Where to buy Pralsetinib is reliable?1. Hos···【more】
Article source：Captain MedicineRelease date：2024-11-14Recommended：438
Elacestrant, a non-steroidal small molecule, is an estrogen receptor (ER) antagonist. Erastratran binds to estrogen receptor α (ERα) and acts as a selective estrogen receptor degra···【more】
Article source：Captain MedicineRelease date：2024-11-13Recommended：414
Balversa is a small molecule inhibitor of fibroblast growth factor receptor (FGFR) used to treat cancer. It is the first personalized treatment drug for susceptible FGFR gene mutat···【more】
Article source：Captain MedicineRelease date：2024-11-13Recommended：509
Retinitis due to cytomegalovirus is indeed a serious eye infection that mainly affects people with weakened immune systems, such as AIDS patients. The virus can continue to damage ···【more】
Article source：Captain MedicineRelease date：2024-11-12Recommended：489
1. Targeted therapySpecific inhibitionAs a tyrosine kinase inhibitor, balversa specifically targets the FGFR (fibroblast growth factor receptor) signaling pathway. FGFR is abnormal···【more】
Article source：Captain MedicineRelease date：2024-11-12Recommended：487
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：[list:visits]2026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：[list:visits]2026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】
Recommended：[list:visits]2026-30-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
